-
Signature
-
/s/ Tami Chen, Attorney-in-Fact
-
Stock symbol
-
NTRA
-
Transactions as of
-
Jan 20, 2025
-
Transactions value $
-
-$160,214
-
Form type
-
4
-
Date filed
-
1/22/2025, 09:45 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NTRA |
Common Stock |
Options Exercise |
|
+191 |
+0.07% |
|
263K |
Jan 20, 2025 |
Direct |
F1 |
transaction |
NTRA |
Common Stock |
Options Exercise |
|
+144 |
+0.05% |
|
263K |
Jan 21, 2025 |
Direct |
F1 |
transaction |
NTRA |
Common Stock |
Sale |
-$159K |
-964 |
-0.37% |
$164.95 |
262K |
Jan 22, 2025 |
Direct |
F2 |
transaction |
NTRA |
Common Stock |
Sale |
-$1.2K |
-7 |
0% |
$171.91 |
262K |
Jan 22, 2025 |
Direct |
F2, F3 |
holding |
NTRA |
Common Stock |
|
|
|
|
|
44.8K |
Jan 20, 2025 |
By Caraluna 1 Trust |
F4 |
holding |
NTRA |
Common Stock |
|
|
|
|
|
44.8K |
Jan 20, 2025 |
By Caraluna 2 Trust |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NTRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-191 |
-20.06% |
$0.00 |
761 |
Jan 20, 2025 |
Common Stock |
191 |
|
Direct |
F1, F5 |
transaction |
NTRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-144 |
-100% |
$0.00 |
0 |
Jan 21, 2025 |
Common Stock |
144 |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: